Xenomics, a developer of next-generation medical DNA technologies, announced today that a team of company scientists has contributed a chapter about the Xenomics' proprietary transrenal DNA technology platform in a new edition of a leading scientific textbook about key advances and topics in the field of modern molecular diagnostic advancements.
Business Wire